Numinus Wellness Inc.
NUMIF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2021 FY | 1.51M | -81.54K | -15.40M | -18.85M | -0.11 |
| 2022 FY | 6.49M | 1.78M | -27.47M | -44.88M | -0.21 |
| 2023 FY | 23.18M | 8.37M | -26.96M | -30.26M | -0.11 |
| 2024 FY | 4.17M | 1.17M | -11.71M | -19.64M | -0.05 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2021 FY | 64.14M | 3.31M | 59.29M | 1.60M | 60.83M |
| 2022 FY | 52.63M | 11.42M | 33.04M | 7.85M | 41.21M |
| 2023 FY | 24.33M | 10.28M | 8.58M | 7.20M | 14.05M |
| 2024 FY | 10.77M | 10.05M | 1.96M | 2.03M | 725.43K |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2021 FY | -15.58M | -641.96K | -16.22M | — | 57.67M |
| 2022 FY | -26.23M | -1.25M | -27.48M | — | -26.25M |
| 2023 FY | -22.76M | -375.45K | -23.14M | — | -24.46M |
| 2024 FY | -17.48M | -25.49K | -17.50M | — | -6.62M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2021 FY | 142.11M | 84.42M | — | — | — |
| 2022 FY | 77.44M | 52.25M | — | — | — |
| 2023 FY | 51.89M | 50.51M | — | — | — |
| 2024 FY | 9.44M | 9.51M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2024 Q4 | -9.80M | -3.22M | -19.93M | -3.53M | -0.01 |
| 2025 Q1 | 2.01M | 1.02M | -875.57K | -1.20M | 0.00 |
| 2025 Q2 | 1.51M | 504.74K | -1.87M | -9.16M | -0.03 |
| 2025 Q3 | 1.80M | 870.10K | -537.58K | -711.19K | 0.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2024 Q4 | 10.77M | 10.05M | 1.96M | 2.03M | 725.43K |
| 2025 Q1 | 10.39M | 10.91M | 2.03M | 2.46M | -517.08K |
| 2025 Q2 | 4.58M | 5.39M | 705.63K | 2.54M | -816.10K |
| 2025 Q3 | 4.29M | 5.84M | 822.84K | 2.32M | -1.55M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2024 Q4 | -7.15M | -40.00 | -7.15M | — | -1.74M |
| 2025 Q1 | 634.40K | -2.00 | 634.40K | — | 70.69K |
| 2025 Q2 | -3.46M | -157.03K | -3.62M | — | -1.32M |
| 2025 Q3 | 390.09K | 2.90K | 392.99K | — | 117.20K |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2024 Q4 | 9.44M | 9.51M | — | — | — |
| 2025 Q1 | 14.80M | 15.22M | — | — | — |
| 2025 Q2 | 11.50M | 13.34M | — | — | — |
| 2025 Q3 | 10.52M | 12.02M | — | — | — |